add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Nymox's New Trial For Benign Prostatic Hyperplasia Drug Records Positive ...RTT News - Nov 23, 2009 ... US Phase 2 studies of NX-1207 indicated positive data from responder analysis, the new clinical trial for benign prostatic hyperplasia or BPH. ... Nymox Releases Positive New Clinical Trial Data on Durability of Benefits for ... CNNMoney.com (press release) Altered PTEN expression; a diagnostic marker for differentiating normal ...7thSpace Interactive (press release) - Nov 25, 2009 Results: PTEN immunoreactivity was present in all normal proliferative endometrium, all simple hyperplasia, 75% of atypical complex hyperplasia and in 48% ... Resistive index: A newly identified predictor of outcome of transurethral ...UroToday - 22 hours ago A total of 572 men aged 51-85 years scheduled to undergo TURP for benign prostatic hyperplasia were prospectively enrolled, and 560 were ultimately ... Dendreon Announces Webcast Presentations at Upcoming Investor ConferencesPR Newswire (press release) - Nov 25, 2009 ... an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. ... Less HRT, Fewer Cases of Possible Breast Cancer PrecursorU.S. News & World Report - - Nov 12, 2009 12 (HealthDay News) -- Declining use of hormone replacement therapy may be driving down rates of a condition called "atypical ductal hyperplasia," a known ... New Key To Puzzle Of Hormone Therapy And Breast CancerScience Daily (press release) - Nov 9, 2009 Atypical ductal hyperplasia is associated with the use of postmenopausal hormone treatment and its rates have decreased with the decline in use of this ... Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, UnilifeSeeking Alpha (blog) - - Nov 25, 2009 Committee For Medicinal Products For Human Use Summary Of Positive Opinion For ...PharmaLive.com (press release) - Nov 20, 2009 The benefits with Silodyx are its ability to improve lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) including ... Committee For Medicinal Products For Human Use Post-Authorisation Summary Of ... PharmaLive.com (press release) Committee For Medicinal Products For Human Use Summary Of Positive Opinion For ... PharmaLive.com (press release) Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia Therapy Area ...PR-Inside.com (Pressemitteilung) - 20 hours ago The Benign Prostatic Hyperplasia Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into ... CASCADE: No significant benefit of clopidogrel in reducing graft disease after ...TheHeart.Org - - Nov 17, 2009 Orlando, FL - There was no significant benefit of one year's treatment with clopidogrel on reducing vein graft intimal hyperplasia in CABG patients in the ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
